Medicinal Chemistry is a dynamic, multifaceted scientific discipline that is dedicated to the improvement of human health through research that leads to the design and development of safe and effective therapeutic, diagnostic, and environmental agents.
Biosafety/ biosecurity, cancer and neurological drug discovery, chemical neuroscience, chemoprevention and carcinogenesis, combinatorial biosynthesis, computer-aided drug design, drug metabolism, gene therapy, high-throughput screening, immunology, NMR, non-hormonal contraception, peptidomimetics and X-ray crystallography.
Faculty Spotlight: Courtney Aldrich
Dr. Aldrich received a $3.8 million NIH grant for the project "Siderophore Inhibitors for Tuberculosis that Block Mycobactin Biosynthesis" on which he is the sole PI. Also, his collaborative research was the focus of a LA times article.
Faculty Spotlight: Natalia Tretyakova
Faculty Spotlight: Gunda Georg
The ITDD carries out interdisciplinary research, helps educate the next generation of scientists, and enhances the biomedical research infrastructure by creating opportunities for drug discovery and early pre-clinical drug development.
Congratulations to Sara Coulup (Georg Lab) and Jian Tang (Harki Lab), who were both selected to receive the 2018-2019 Bighley Graduate Fellowship! The fellowship was established in 2008 by Dr. Lyle D. Bighley and Sharon Bighley as a way to support graduate students working in the biomedical health sciences. It recognizes excellence in students conducting research in laboratories with an emphasis on collaborative and interdisciplinary work.
Congratulations to Kellan Passow, graduate student in the Harki laboratory, who was awarded the American Chemical Society, Minnesota Section Travel Grant! The grant will provide funds for Kellan to attend the Fall 2018 ACS meeting in Boston, Massachusetts where he will make a presentation on his research.
The research of Dr. Carston Wagner and his lab was featured in a recent Minnesota Daily article titled "UMN Researchers Attacking Cancer Cells with Nanotechnology." The article highlights the Wagner lab's steps towards clinical trials, in discussion with the U.S. Food and Drug Administration, for their nanoring therapy. The nanotherapy modifies the user's own T cells in order to reactivate the immune system to target cancer cells. Unlike other methods to kill tumor cells, the nanoring therapy is reversible and does not carry long-term risks.
Professor Rory Remmel attended the 49th Gordon Research Conference in Drug Metabolism last week at Holderness Academy near Plymouth, New Hampshire. Dr. Swati Nagar (recently promoted to full professor at Temple University) chaired the meeting. She was a PHD student of Professor Emeritus Cheryl Zimmerman and co-advised by Dr. Remmel. Three of Dr. Remmel's former PhD students, Vinayak Hosagrahara, Upendra Argikar, and Aaron Teitelbaum were also in attendance. Dr. Steven Leeder (Minnesota PharmD, 1982) was elected as the academic vice chair.
Make use of the Department's over 30,000 square feet of modern research laboratory space located within the Academic Health Center and the Biomedical Discovery District. Read more about our instrumentation, laboratories, facilities and facaulty research.